Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 7.179 Q1 | 254 | 22 | 69 | 6579 | 1423 | 68 | 17.44 | 299.05 | |
2 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 1 | 9 | 299 | 2 | 9 | 0.33 | 299.00 | ||
3 | Drug Resistance Updates | journal | 3.920 Q1 | 132 | 17 | 66 | 3750 | 944 | 66 | 11.09 | 220.59 | |
4 | Pharmacology and Therapeutics | journal | 3.348 Q1 | 233 | 148 | 433 | 31691 | 4647 | 433 | 10.87 | 214.13 | |
5 | Medicinal Research Reviews | journal | 2.385 Q1 | 150 | 71 | 124 | 14425 | 1245 | 122 | 9.35 | 203.17 | |
6 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.639 Q1 | 82 | 13 | 44 | 2594 | 136 | 44 | 2.20 | 199.54 | |
7 | Advanced Drug Delivery Reviews | journal | 4.082 Q1 | 366 | 160 | 522 | 31288 | 8488 | 478 | 12.49 | 195.55 | |
8 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.766 Q1 | 99 | 9 | 63 | 1600 | 430 | 58 | 5.61 | 177.78 | |
9 | Critical Reviews in Toxicology | journal | 1.107 Q1 | 129 | 38 | 128 | 6684 | 545 | 124 | 4.10 | 175.89 | |
10 | Frontiers in Clinical Drug Research - Alzheimer Disorders | book series | 3 | 7 | 0 | 1140 | 0 | 0 | 0.00 | 162.86 | ||
11 | Natural Product Reports | journal | 3.421 Q1 | 211 | 75 | 202 | 11909 | 2253 | 195 | 10.69 | 158.79 | |
12 | Nano Today | journal | 6.198 Q1 | 175 | 58 | 147 | 9149 | 2792 | 139 | 18.20 | 157.74 | |
13 | NTP monograph | journal | 2 | 3 | 0 | 467 | 0 | 0 | 0.00 | 155.67 | ||
14 | WikiJournal of Medicine | journal | 4 | 8 | 0 | 1177 | 0 | 0 | 0.00 | 147.13 | ||
15 | Annual Review of Pharmacology and Toxicology | journal | 5.153 Q1 | 224 | 29 | 92 | 4022 | 1170 | 92 | 12.16 | 138.69 | |
16 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 2 | 7 | 0 | 948 | 0 | 0 | 0.00 | 135.43 | ||
17 | Drug Metabolism Reviews | journal | 1.119 Q1 | 108 | 32 | 79 | 4301 | 372 | 79 | 4.41 | 134.41 | |
18 | Current Neuropharmacology | journal | 1.531 Q1 | 103 | 84 | 319 | 11035 | 1560 | 286 | 4.51 | 131.37 | |
19 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 10 | 257 | 0 | 10 | 0.00 | 128.50 | ||
20 | Studies in Natural Products Chemistry | book series | 0.123 Q4 | 49 | 30 | 200 | 3799 | 218 | 13 | 1.06 | 126.63 | |
21 | Current Medicinal Chemistry | journal | 0.903 Q1 | 202 | 432 | 892 | 53007 | 3275 | 828 | 3.62 | 122.70 | |
22 | Cellular and Molecular Life Sciences | journal | 2.970 Q1 | 261 | 305 | 876 | 36488 | 6523 | 865 | 6.65 | 119.63 | |
23 | Reference Series in Phytochemistry | book series | 19 | 148 | 104 | 16688 | 71 | 0 | 0.68 | 112.76 | ||
24 | Current Drug Targets | journal | 0.741 Q2 | 119 | 139 | 552 | 15568 | 1470 | 500 | 2.63 | 112.00 | |
25 | Antibodies | journal | 0.261 Q3 | 42 | 56 | 85 | 6051 | 164 | 83 | 1.83 | 108.05 | |
26 | Progress in Medicinal Chemistry | journal | 0.523 Q3 | 38 | 5 | 17 | 534 | 46 | 4 | 3.73 | 106.80 | |
27 | Expert Opinion on Drug Delivery | journal | 1.001 Q1 | 133 | 106 | 361 | 11229 | 1829 | 334 | 4.92 | 105.93 | |
28 | Current Pharmaceutical Design | journal | 0.606 Q2 | 183 | 450 | 1768 | 47168 | 4305 | 1639 | 2.23 | 104.82 | |
29 | Expert Opinion on Therapeutic Targets | journal | 1.699 Q1 | 106 | 91 | 319 | 9499 | 1532 | 280 | 4.80 | 104.38 | |
30 | Advanced Therapeutics | journal | 39 | 102 | 53 | 10443 | 230 | 52 | 4.34 | 102.38 | ||
31 | RSC Drug Discovery Series | book series | 0.104 Q4 | 13 | 128 | 232 | 13102 | 83 | 22 | 0.36 | 102.36 | |
32 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q2 | 52 | 29 | 94 | 2940 | 250 | 91 | 2.75 | 101.38 | |
33 | Handbook of Experimental Pharmacology | journal | 1.559 Q1 | 110 | 124 | 310 | 12247 | 926 | 30 | 2.84 | 98.77 | |
34 | Frontiers in Anti-infective Drug Discovery | book series | 3 | 8 | 0 | 784 | 0 | 0 | 0.00 | 98.00 | ||
35 | Pharmacological Research | journal | 1.609 Q1 | 169 | 409 | 1045 | 39457 | 5936 | 962 | 5.63 | 96.47 | |
36 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 17 | 45 | 1636 | 102 | 43 | 1.93 | 96.24 | ||
37 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.930 Q1 | 100 | 88 | 373 | 8459 | 1290 | 343 | 3.62 | 96.13 | |
38 | Current Topics in Medicinal Chemistry | journal | 0.788 Q2 | 133 | 231 | 798 | 22201 | 2546 | 687 | 2.90 | 96.11 | |
39 | Expert Review of Vaccines | journal | 1.746 Q1 | 105 | 102 | 353 | 9704 | 1450 | 312 | 4.40 | 95.14 | |
40 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 1 | 7 | 0 | 662 | 0 | 0 | 0.00 | 94.57 | ||
41 | Expert Opinion on Drug Discovery | journal | 1.160 Q1 | 84 | 112 | 313 | 10359 | 1381 | 271 | 4.50 | 92.49 | |
42 | British Journal of Pharmacology | journal | 2.493 Q1 | 244 | 329 | 936 | 29968 | 6475 | 887 | 7.34 | 91.09 | |
43 | Expert Opinion on Emerging Drugs | journal | 0.801 Q2 | 54 | 21 | 95 | 1879 | 300 | 90 | 3.11 | 89.48 | |
44 | Current Molecular Pharmacology | journal | 0.629 Q2 | 49 | 28 | 98 | 2442 | 237 | 85 | 2.87 | 87.21 | |
45 | Expert Opinion on Therapeutic Patents | journal | 1.027 Q1 | 88 | 73 | 290 | 6360 | 1385 | 281 | 5.41 | 87.12 | |
46 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.714 Q1 | 150 | 278 | 648 | 24129 | 3013 | 637 | 4.55 | 86.79 | |
47 | Drug Discovery Today: Disease Models | journal | 0.252 Q3 | 33 | 7 | 80 | 607 | 42 | 71 | 0.46 | 86.71 | |
48 | Current Drug Metabolism | journal | 0.650 Q2 | 122 | 122 | 305 | 10562 | 888 | 280 | 2.72 | 86.57 | |
49 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.330 Q3 | 45 | 27 | 69 | 2335 | 104 | 65 | 1.42 | 86.48 | |
50 | Journal of International Peacekeeping | journal | 0.121 Q4 | 14 | 5 | 51 | 430 | 5 | 47 | 0.07 | 86.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®